Actively Recruiting
HPV Ends Here: Increasing Uptake of the HPV Vaccine
Led by University of California, Davis · Updated on 2025-04-25
2232
Participants Needed
1
Research Sites
95 weeks
Total Duration
On this page
Sponsors
U
University of California, Davis
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Develop, implement, and evaluate a culturally tailored multilevel intervention to increase uptake of the HPV vaccine among eligible patients ages 10-12 of the University of California, Davis Health Community Physician (UCDH CP) primary care practices using a randomized controlled trial design.
CONDITIONS
Official Title
HPV Ends Here: Increasing Uptake of the HPV Vaccine
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinic patients between the ages of 10-12 who are eligible for the HPV vaccine
You will not qualify if you...
- Clinic patients who already received the HPV vaccine or with any contraindication to the HPV vaccine.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California Davis Health
Sacramento, California, United States, 95817
Actively Recruiting
Research Team
R
Ramneek Kahlon, BS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here